Alveolar soft part sarcoma (ASPS)
Showing 26 - 50 of >10,000
Soft Tissue Volume Changes in Posterior Socket Sealing Abutment.
Recruiting
- Dental Implants
- Immediate dental implant placement
-
Alicante, SpainClínica Dental esteve
Feb 8, 2023
Soft Tissue Sarcoma Adult, Angiosarcoma, Undifferentiated Pleomorphic Sarcoma Trial in Denmark, Norway, Sweden (Propranolol,
Recruiting
- Soft Tissue Sarcoma Adult
- +2 more
-
Aarhus, Denmark
- +3 more
Jul 23, 2023
Soft Tissue Thickness Trial (Socket seal after alveolar ridge preservation)
Not yet recruiting
- Soft Tissue Thickness
- Socket seal after alveolar ridge preservation
- (no location specified)
Aug 31, 2023
Soft Tissue Sarcoma Trial in Guangzhou (TAEST16001 cells)
Active, not recruiting
- Soft Tissue Sarcoma
- TAEST16001 cells
-
Guangzhou, Guangdong, ChinaXing Zhang
Dec 13, 2022
Alveolar Ridge Preservation Trial in Cairo (biologically oriented alveolar ridge preservation, xenogenic bone graft in entire
Not yet recruiting
- Alveolar Ridge Preservation
- biologically oriented alveolar ridge preservation
- xenogenic bone graft in entire (apico-coronal) extension
-
Cairo, Giza, EgyptCairo University
Sep 21, 2022
Advanced Sarcoma, Metastatic Sarcoma, Soft Tissue Sarcoma Trial (YH001, Envafolimab, Doxorubicin)
Recruiting
- Advanced Sarcoma
- +2 more
- YH001
- +2 more
-
Santa Monica, CaliforniaSarcoma Oncology Center
Dec 5, 2022
Ewing Sarcoma, Ewing Sarcoma of Bone, Ewing Sarcoma of Soft Tissue Trial in United States (FoundationOne Liquid CDx)
Recruiting
- Ewing Sarcoma
- +6 more
- FoundationOne Liquid CDx
-
Los Angeles, California
- +14 more
Oct 5, 2023
Pediatric Sarcoma, Refractory, Pediatric Sarcoma, Relapsed Trial in Tampa, Columbus (GEM/DOX + TGFBi expanded NK cells)
Recruiting
- Pediatric Sarcoma, Refractory
- Pediatric Sarcoma, Relapsed
- GEM/DOX + TGFBi expanded NK cells
-
Tampa, Florida
- +1 more
Jan 3, 2023
Dental Implant Failed, Implant Site Reaction Trial (Sub-crestal implant, Equi-crestal implant)
Not yet recruiting
- Dental Implant Failed
- Implant Site Reaction
- Sub-crestal implant
- Equi-crestal implant
- (no location specified)
Aug 1, 2023
Soft Tissue Sarcoma, Bone Sarcoma Trial in Houston (Cyclophosphamide, attIL2-T cells)
Not yet recruiting
- Soft Tissue Sarcoma
- Bone Sarcoma
- Cyclophosphamide
- attIL2-T cells
-
Houston, TexasM D Anderson Cancer Center
Nov 10, 2022
Retrospective Study in Sarcoma Patients
Completed
- Sarcoma of Bone
- Sarcoma of Soft Tissue
-
Greifswald, GermanyUniversity Medicine Greifswald, Department of Internal Medicine
Nov 5, 2021
Alveolar Bone Loss Trial in Piracicaba (Control group, Mixed free gingival graft group, Bone+ mixed free gingival graft group)
Recruiting
- Alveolar Bone Loss
- Control group
- +3 more
-
Piracicaba, São Paulo, BrazilPiracicaba Dental School
Oct 6, 2023
Sarcoma,Soft Tissue Trial in Guangzhou (anlotinib and toripalimab)
Recruiting
- Sarcoma,Soft Tissue
- anlotinib and toripalimab
-
Guangzhou, Guangdong, ChinaXing Zhang
Nov 15, 2021
Alveolar Soft-part Sarcoma Trial in Australia, Spain, United Kingdom (Cediranib, Placebo)
Unknown status
- Alveolar Soft-part Sarcoma
- Cediranib
- Placebo
-
Brisbane, Australia
- +10 more
Jan 22, 2019
Soft Tissue Sarcoma Trial in Toronto (Radiotherapy, Surgery)
Not yet recruiting
- Soft Tissue Sarcoma
- Radiotherapy
- Surgery
-
Toronto, Ontario, CanadaUniversity Health Network
Jul 10, 2023
Sarcoma, Soft Tissue Trial in Changsha (Cardunilizumab)
Active, not recruiting
- Sarcoma, Soft Tissue
-
Changsha, Hunan, ChinaXiangya Hospital Central South University
Oct 29, 2023
Rhabdomyosarcoma in Adolescents and Young Adults, 15-25-year-old
Active, not recruiting
- Rhabdomyosarcoma
-
Bordeaux, France
- +19 more
Jul 19, 2022
Soft Tissue Sarcoma Trial in Copenhagen (LTX-315 and TILs)
Active, not recruiting
- Soft Tissue Sarcoma
- LTX-315 and TILs
-
Copenhagen, DenmarkHerlev Hospital
Aug 27, 2021
Soft Tissue Sarcoma Trial in Worldwide (trofosfamide, idarubicin, etoposide)
Active, not recruiting
- Soft Tissue Sarcoma
- trofosfamide, idarubicin, etoposide
-
Graz, Austria
- +73 more
Nov 12, 2021
Sarcoma, Soft Tissue Trial in Beijing (609A, doxorubicin HCl)
Not yet recruiting
- Sarcoma, Soft Tissue
- 609A
- doxorubicin hydrochloride
-
Beijing, Beijing, ChinaBeijing ji shui tan Hospital
Nov 17, 2021